Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119M
-
Number of holders
-
119
-
Total 13F shares, excl. options
-
39.5M
-
Shares change
-
+158K
-
Total reported value, excl. options
-
$250M
-
Value change
-
+$228K
-
Put/Call ratio
-
1.91
-
Number of buys
-
59
-
Number of sells
-
-40
-
Price
-
$6.32
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q4 2018
131 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q4 2018.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.5M shares
of 119M outstanding shares and own 33.12% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.73M shares), BVF INC/IL (4.15M shares), Vanguard Group Inc (3.6M shares), GREAT POINT PARTNERS LLC (3.17M shares), LANSDOWNE PARTNERS (UK) LLP (2.65M shares), WASATCH ADVISORS INC (2.46M shares), STATE STREET CORP (1.92M shares), FMR LLC (1.85M shares), RP Management, LLC (876K shares), and WELLINGTON MANAGEMENT GROUP LLP (770K shares).
This table shows the top 119 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.